Zacks Investment ResearchFri, 26 Jun 2026 16:05:36 GMTNurix Stock Up 29% in a Month: Here's What You Should KnowNRIX+2.69%
Zacks Investment ResearchFri, 26 Jun 2026 15:45:32 GMTNurix Therapeutics (NRIX) Soars 16.4%: Is Further Upside Left in the Stock?NRIX+2.69%
Seeking AlphaThu, 11 Jun 2026 13:48:54 GMTNurix Therapeutics Deal With Roche Is Worth Betting OnNRIX+2.69%
Seeking AlphaTue, 09 Jun 2026 13:59:00 GMTNurix Therapeutics: 'Strong Buy' Due To Roche Deal And Bexobrutideg ExpansionsNRIX+2.69%
Zacks Investment ResearchTue, 09 Jun 2026 11:26:09 GMTStrength Seen in Nurix Therapeutics (NRIX): Can Its 6.8% Jump Turn into More Strength?NRIX+2.69%
Seeking AlphaMon, 08 Jun 2026 20:58:35 GMTNurix Therapeutics, Inc. (NRIX) Discusses Strategic Collaboration for Development and Commercialization of Bexobrutideg for BTK-Mediated Diseases TranscriptNRIX+2.69%
Zacks Investment ResearchMon, 08 Jun 2026 16:46:47 GMTRoche, Nurix Team Up to Advance BTK Degrader BexobrutidegNRIX+2.69%
BarronsMon, 08 Jun 2026 14:08:00 GMTThis Biotech Stock Is Up 11% on $2.3 Billion Roche Deal for Blood Cancer DrugNRIX+2.69%
Investors Business DailyMon, 08 Jun 2026 14:06:42 GMTRoche Inks $2.3 Billion Deal, Sending This Small Biotech Stock FlyingNRIX+2.69%
BenzingaMon, 08 Jun 2026 13:26:57 GMTNurix Therapeutics Gains Ground As Roche Partnership Targets Growing B-Cell Blood Cancer MarketNRIX+2.69%
WSJMon, 08 Jun 2026 05:47:00 GMTRoche Enters $2.3 Billion Blood-Cancer Drug Deal With Nurix TherapeuticsNRIX+2.69%
Seeking AlphaFri, 22 May 2026 22:20:44 GMTNurix Therapeutics, Inc. (NRIX) Presents at RBC Capital Markets Global Healthcare Conference 2026 TranscriptNRIX+2.69%
Seeking AlphaFri, 17 Apr 2026 10:51:47 GMTNurix Therapeutics, Inc. (NRIX) Presents at 25th Annual Needham Virtual Healthcare Conference TranscriptNRIX+2.69%
Zacks Investment ResearchFri, 10 Apr 2026 14:56:18 GMTDoes Nurix Therapeutics (NRIX) Have the Potential to Rally 85.84% as Wall Street Analysts Expect?NRIX+2.69%
Seeking AlphaThu, 09 Apr 2026 19:49:00 GMTNurix: 'Strong Buy' Bexobruditeg Development And Dual Degrader ZelebrudomideNRIX+2.69%
Zacks Investment ResearchWed, 08 Apr 2026 12:12:05 GMTNurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Lags Revenue EstimatesNRIX+2.69%
